首页 › 阻塞性睡眠呼吸暂停 › 俄亥俄州 › Cincinnati
Cincinnati OH 阻塞性睡眠呼吸暂停临床试验
8项针对 阻塞性睡眠呼吸暂停的研究正在 Cincinnati及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Down Syndrome Obstructive Sleep Apnea
招募中2 期
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
招募中3 期
- CTI Clinical Research Center, Cincinnati
DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.
招募中2 期
- CTI Clinical Research Center, Cincinnati
- Intrepid Research, Cincinnati
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
招募中3 期
- CTI Clinical Research Center, Cincinnati
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
招募中3 期
- CTI Clinical Research Center, Cincinnati
Comparison of a Demand Oxygen Delivery
招募中欢迎健康志愿者
- Cincinnati Children's Hospital Medical Center, Cincinnati
Improving Outcomes in Pediatric Obstructive Sleep Apnea With Computational Fluid Dynamics
招募中4 期
- Cincinnati Children's Hospital Medical Center, Cincinnati
Pediatric Post-Approval Registry
招募中观察性研究
- Cincinnati Childrens Hospital, Cincinnati
其他城市的 阻塞性睡眠呼吸暂停试验
- Boston, MA9 项研究
- Ann Arbor, MI8 项研究
- Philadelphia, PA8 项研究
- Chicago, IL8 项研究
- Miami, FL7 项研究
- San Diego, CA7 项研究
- New York City, NY6 项研究
- Pittsburgh, PA5 项研究
- Washington, DC5 项研究
- Seattle, WA5 项研究
- Rochester, MN4 项研究
- Dallas, TX4 项研究
Cincinnati的其他研究
- 非小细胞肺癌35 项研究
- 癌症（所有类型）27 项研究
- 乳腺癌25 项研究
- 心力衰竭24 项研究
- 结直肠癌21 项研究
- 急性髓系白血病20 项研究
- 转移性癌症20 项研究
- 卵巢癌19 项研究
- 肺癌19 项研究
- 肥胖症19 项研究
- 前列腺癌18 项研究
- 多发性骨髓瘤17 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。